These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 31068771)

  • 1. Off-Label Use of Bumetanide for Brain Disorders: An Overview.
    Kharod SC; Kang SK; Kadam SD
    Front Neurosci; 2019; 13():310. PubMed ID: 31068771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS pharmacology of NKCC1 inhibitors.
    Löscher W; Kaila K
    Neuropharmacology; 2022 Mar; 205():108910. PubMed ID: 34883135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures.
    Kahle KT; Staley KJ
    Neurosurg Focus; 2008 Sep; 25(3):E22. PubMed ID: 18759624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the NKCC1 inhibitors bumetanide, azosemide, and torasemide alone or in combination with phenobarbital on seizure threshold in epileptic and nonepileptic mice.
    Hampel P; Römermann K; Gailus B; Johne M; Gericke B; Kaczmarek E; Löscher W
    Neuropharmacology; 2021 Mar; 185():108449. PubMed ID: 33450274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy.
    Brandt C; Seja P; Töllner K; Römermann K; Hampel P; Kalesse M; Kipper A; Feit PW; Lykke K; Toft-Bertelsen TL; Paavilainen P; Spoljaric I; Puskarjov M; MacAulay N; Kaila K; Löscher W
    Neuropharmacology; 2018 Dec; 143():186-204. PubMed ID: 30248303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients with Drug-Resistant Epilepsy.
    Gharaylou Z; Tafakhori A; Agah E; Aghamollaii V; Kebriaeezadeh A; Hadjighassem M
    CNS Drugs; 2019 Mar; 33(3):283-291. PubMed ID: 30784026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age- and sex-dependent susceptibility to phenobarbital-resistant neonatal seizures: role of chloride co-transporters.
    Kang SK; Markowitz GJ; Kim ST; Johnston MV; Kadam SD
    Front Cell Neurosci; 2015; 9():173. PubMed ID: 26029047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of bumetanide as a potential therapeutic agent for Alzheimer's disease.
    Boyarko B; Podvin S; Greenberg B; Momper JD; Huang Y; Gerwick WH; Bang AG; Quinti L; Griciuc A; Kim DY; Tanzi RE; Feldman HH; Hook V
    Front Pharmacol; 2023; 14():1190402. PubMed ID: 37601062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological tools to target NKCC1 in brain disorders.
    Savardi A; Borgogno M; De Vivo M; Cancedda L
    Trends Pharmacol Sci; 2021 Dec; 42(12):1009-1034. PubMed ID: 34620512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo effects of bumetanide at brain concentrations incompatible with NKCC1 inhibition on newborn DGC structure and spontaneous EEG seizures following hypoxia-induced neonatal seizures.
    Wang S; Zhang XQ; Song CG; Xiao T; Zhao M; Zhu G; Zhao CS
    Neuroscience; 2015 Feb; 286():203-15. PubMed ID: 25463517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NKCC1 transporter facilitates seizures in the developing brain.
    Dzhala VI; Talos DM; Sdrulla DA; Brumback AC; Mathews GC; Benke TA; Delpire E; Jensen FE; Staley KJ
    Nat Med; 2005 Nov; 11(11):1205-13. PubMed ID: 16227993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments.
    Löscher W; Puskarjov M; Kaila K
    Neuropharmacology; 2013 Jun; 69():62-74. PubMed ID: 22705273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a Small Molecule Drug Candidate for Selective NKCC1 Inhibition in Brain Disorders.
    Savardi A; Borgogno M; Narducci R; La Sala G; Ortega JA; Summa M; Armirotti A; Bertorelli R; Contestabile A; De Vivo M; Cancedda L
    Chem; 2020 Aug; 6(8):2073-2096. PubMed ID: 32818158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of NKCC1 and KCC2 in Epilepsy: From Expression to Function.
    Liu R; Wang J; Liang S; Zhang G; Yang X
    Front Neurol; 2019; 10():1407. PubMed ID: 32010056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The search for NKCC1-selective drugs for the treatment of epilepsy: Structure-function relationship of bumetanide and various bumetanide derivatives in inhibiting the human cation-chloride cotransporter NKCC1A.
    Lykke K; Töllner K; Feit PW; Erker T; MacAulay N; Löscher W
    Epilepsy Behav; 2016 Jun; 59():42-9. PubMed ID: 27088517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat NKCC2/NKCC1 cotransporter selectivity for loop diuretic drugs.
    Hannaert P; Alvarez-Guerra M; Pirot D; Nazaret C; Garay RP
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):193-9. PubMed ID: 11882915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gain-of-function missense variant in SLC12A2, encoding the bumetanide-sensitive NKCC1 cotransporter, identified in human schizophrenia.
    Merner ND; Mercado A; Khanna AR; Hodgkinson A; Bruat V; Awadalla P; Gamba G; Rouleau GA; Kahle KT
    J Psychiatr Res; 2016 Jun; 77():22-6. PubMed ID: 26955005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Concepts for the Role of Chloride Cotransporters in Refractory Seizures.
    Kipnis PA; Kadam SD
    Aging Dis; 2021 Jul; 12(4):1056-1069. PubMed ID: 34221549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding Spectrum of Sodium Potassium Chloride Co-transporters in the Pathophysiology of Diseases.
    Jaggi AS; Kaur A; Bali A; Singh N
    Curr Neuropharmacol; 2015; 13(3):369-88. PubMed ID: 26411965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seizures regulate the cation-Cl
    Bonet-Fernández JM; Tranque P; Aroca-Aguilar JD; Muñoz LJ; López DE; Escribano J; de Cabo C
    Front Neurol; 2023; 14():1207616. PubMed ID: 37448751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.